Medicine for treating prostatitis

Abstract

A medicine for treating prostatitis, comprising (amount by weight): 4-30 parts of Scutellaria barbata, 4-20 parts of Fenzhi, 3-15 parts of Radix Paeoniae Rubra, 3-15 parts of Patrinia, and Achyranthes bidentata 1 to 10 parts, 1 to 10 parts of Tangerine Pit, 1 to 10 parts of Wang Buliuxing, prepared according to conventional preparation methods. The drug efficacy test of the present invention proves that it can reduce the prostate viscera coefficients of two kinds of model rats with chronic non-bacterial prostatitis caused by Xiaozhiling injection and cross vegetable gum, and improve the pathological and histological changes of the model rats; Reduce the weight of cotton ball granuloma in rats, reduce the swelling rate of paws after egg white-induced inflammation; inhibit xylene-induced ear swelling in mice; increase the pain threshold of mice induced by hot plate method; reduce the number of writhing in mice induced by acetic acid. It shows that it has anti-inflammatory and analgesic effects, and has a therapeutic effect on chronic non-bacterial prostatitis in rats.

Description

technical field [0001] The invention belongs to the technical field of medical preparations containing raw materials or their reaction products with unknown structures, and specifically relates to materials derived from plants. Background technique [0002] Prostatitis has always been one of the main problems in andrology and urology. The incidence rate in the population varies greatly, and the results of various studies are not the same. The health statistics of the International Health Center show that the incidence of prostatitis was about 25% from 1977 to 1978; 35% to 50% of men will be affected by prostatitis at some point in their lives. Pavone et al. reported that nearly 18.9% of Italian urology outpatients visited a doctor due to recurrent clinical symptoms of prostatitis. In my country, prostatitis accounts for about 1 / 3 of the total number of outpatients in urology and andrology. Prostatitis is a common disease in adult men, which has a serious impact on the phys...

AI Technical Summary

Problems solved by technology

Among them, chronic nonbacterial prostatitis accounts for 64%, and its etiology is still unclear. Based on the literature review on chronic nonbacterial prostatitis, it is believed that due to the understanding of the etiology and pathophysiological mechanism of chronic nonbacterial prostatitis Not enough, therefore, the ideal treatment effect has not yet been achieved

Chronic non-bacterial prostatitis accounts for the vast majority of prostatitis. At present, some progress has been made in its etiology, epidemiology, diagnosis and treatment. However, because its etiology and pathogenesis have not been fully elucidated, Western medicine often lacks thorough and effective treatment Therapeutic drugs lead to low cure rate and high recurrence rate of the disease, which obviously affects the quality of life of patients